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Abstract
Background: Possible serious bacterial infection (PBSI) is a major cause of neonatal mortality worldwide. We
studied risk factors for PSBI in a large rural population in central India where facility deliveries have increased as a
result of a government financial assistance program.
Methods: We studied 37,379 pregnant women and their singleton live born infants with birth weight ≥ 1.5 kg from
20 rural primary health centers around Nagpur, India, using data from the 2010–13 population-based Maternal and
Newborn Health Registry supported by NICHD’s Global Network for Women’s and Children’s Health Research.
Factors associated with PSBI were identified using multivariable Poisson regression.
Results: Two thousand one hundred twenty-three infants (6 %) had PSBI. Risk factors for PSBI included nulliparity
(RR 1.13, 95 % CI 1.03–1.23), parity > 2 (RR 1.30, 95 % CI 1.07–1.57) compared to parity 1–2, first antenatal care visit
in the 2nd/3rd trimester (RR 1.46, 95 % CI 1.08–1.98) compared to 1st trimester, administration of antenatal
corticosteroids (RR 2.04, 95 % CI 1.60–2.61), low birth weight (RR 3.10, 95 % CI 2.17–4.42), male sex (RR 1.20, 95 % CI
1.10–1.31) and lack of early initiation of breastfeeding (RR 3.87, 95 % CI 2.69–5.58).
Conclusion: Infants who are low birth weight, born to mothers who present late to antenatal care or receive
antenatal corticosteroids, or born to nulliparous women or those with a parity > 2, could be targeted for
interventions before and after delivery to improve early recognition of signs and symptoms of PSBI and prompt
referral. There also appears to be a need for a renewed focus on promoting early initiation of breastfeeding
following delivery in facilities.
Trial registration: This trial is registered at ClinicalTrials.gov (NCT01073475).
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Background
Serious bacterial infection, such as meningitis, pneumo-
nia and sepsis, is a significant cause of morbidity and
mortality in neonates. Worldwide, there were an esti-
mated 6.9 million cases in 2012 and each year serious
bacterial infection is responsible for one-fifth of neonatal
deaths [1, 2]. Diagnosis is challenging even in high-
resource settings since signs and symptoms in neonates
are often non-specific. In resource-limited settings where
access to laboratory facilities is limited, diagnosis of pos-
sible serious bacterial infection (PSBI) has relied on vali-
dated clinical algorithms to identify those who would
benefit from antibiotic therapy [3]. PSBI has an esti-
mated 10 percent case fatality risk; therefore early diag-
nosis and treatment could save hundreds of thousands
of lives [2, 4]. India bears a high burden of disease, ac-
counting for one-quarter of all neonatal deaths, with
more than 25 percent attributable to serious bacterial in-
fections [5].
Risk factors for neonatal infection in resource-limited
settings have mostly been studied in children admitted
to facilities and have examined the outcome of clinical
or culture-confirmed sepsis. These studies have shown
* Correspondence: marie.wang@childrens.harvard.edu
1Division of Infectious Diseases, Department of Medicine, Boston Children’s
Hospital, Boston, MA, USA
2Division of Global Health, Department of Pediatrics, Massachusetts General
Hospital, Boston, MA, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wang et al. BMC Public Health  (2016) 16:1097 
DOI 10.1186/s12889-016-3688-3
that prematurity, low birth weight, prolonged rupture of
membranes and maternal fever are important risk factors
for neonatal sepsis, similar to resource-rich settings [6–8].
Delivery at health care facilities and skilled birth attend-
ance has been advocated to reduce neonatal mortality,
prompting the implementation of policies such as India’s
conditional cash transfer scheme (Janani Suraksha Yojana)
in 2005 to incentivize deliveries at facilities [9, 10]. The
rates of facility delivery vary widely across India, ranging
from 32–62 % in 2007–08 [11], with some areas reaching
facility delivery rates greater than 90 % from 2010–2013
[12]. While facility-based delivery has the potential to im-
prove newborn outcomes, poor infection control practices
intrapartum and postpartum may contribute to the devel-
opment of neonatal infections [13]. Although much has
been published on PSBI in India over the last twenty
years, the effect of the recent rapid change to high rates of
facility delivery in India on risk factors for PSBI in the
community remains less clear.
Population-based data are needed to address the full
burden of PSBI, since many neonates with signs of infec-
tion, even those born in facilities, may develop signs of
infection at home after discharge and do not return to a
facility for evaluation. To our knowledge, there are no
published population-based data on risk factors for PSBI
in resource-limited settings where the overwhelming ma-
jority of births (>90 %) occur in facilities [2]. Identification
of babies at highest risk for PSBI is important to further
reduce neonatal mortality from PSBI. Our objective was
to describe the burden of and risk factors for PSBI in in-
fants from 0–6 weeks of age in a prospective population-
based pregnancy registry in central India in the era of
facility deliveries.
Methods
Study design and setting
We analyzed data from the Nagpur, India site of the Ma-
ternal and Newborn Health Registry (MNHR) collected
between January 1, 2010 and December 31, 2013. The
MNHR is a multi-country prospective, population-based
observational study established by the Eunice Kennedy
Shriver National Institute of Child Health and Human De-
velopment (NICHD) Global Network for Women's and
Children's Health Research to track pregnancy and birth
outcomes. The MNHR study site in Nagpur, India, covers
a catchment area of 20 rural primary health centers with
an estimated total population of approximately 536,000
people in 2010.
Study procedures
Details of the MNHR study design and implementation
have been published previously [14]. Briefly, registry ad-
ministrators identified eligible pregnant women; 99.9 %
consented to participate. Registry administrators visited
participants within one week after delivery and collected
information about the pregnancy, delivery and maternal
and neonatal outcomes through interviews with family,
birth attendants and review of available medical records.
They again visited participants at six weeks postpartum
and collected information about maternal and neonatal
adverse conditions from delivery until six weeks of age.
If the infant died, a basic death audit was conducted.
Data were transmitted weekly to the data coordinating
center at RTI International.
Inclusion and exclusion criteria
We included all live born singleton infants with a birth
weight of 1.5 kg and above. Babies weighing less than
1.5 kg were excluded because morbidity and mortality in
this group is more likely related to their prematurity ra-
ther than just infection alone. Reported stillbirths, mis-
carriages and abortions were excluded. Infants were also
excluded if birth weight information was missing or
taken after seven days of age, or if there was no follow-
up information at six weeks of age.
Assessment of exposure variables
Information regarding maternal age and education, parity,
and hemoglobin was collected at enrollment. Information
on antenatal care seeking, pregnancy complications, deliv-
ery mode and location, maternal and neonatal treatment,
and breastfeeding was collected at the first postpartum
visit. This information was collected by medical officers
from parents, birth attendants and review of available med-
ical records. Delivery location was categorized as home/
other or as referral government center (e.g. district or other
government hospitals), referral private center (e.g. private
clinics, nursing homes), or first level facility (public health
center or sub-center) based on facility codes. Most referral
government and private centers had the capability to per-
form C-sections, while first level facilities did not. Presence
of prolonged or obstructed labor/failure to progress was in-
dicated as a single variable in the MNHR and determined
according to adapted WHO definitions. Birth weight was
usually obtained on the day of birth using study scales.
Low birth weight was defined as 1.5- < 2.5 kg. Initiation of
breastfeeding within one hour of delivery was based on
maternal report. Gestational age was not included due to
concerns about the accuracy of the last reported menstrual
period and lack of ultrasound availability to confirm gesta-
tional age. No data on income were collected.
Receipt of antenatal corticosteroids was identified
through the MNHR and through data collected for the
Antenatal Corticosteroid Trial (ACT), an 18-month
cluster-randomized trial conducted by the Global Net-
work in six countries to identify women at risk of preterm
birth and promote appropriate use of antenatal corticoste-
roids [15]. In Nagpur, the trial was implemented in ten
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intervention clusters within the MNHR study area be-
tween June 11, 2012-December 11, 2013. Mothers could
have also received corticosteroids outside the ACT study
at their delivery facility, as antenatal corticosteroids were
also available in some tertiary care centers.
Case Definition of Possible Serious Bacterial Infection (PSBI)
We defined PSBI based on a modified version of the Young
Infant Clinical Signs Study criteria [3, 16]. The presence or
absence of PSBI signs and symptoms in infants 0-6 weeks
of age was recorded by registry administrators retrospect-
ively within one week of delivery and again at six weeks of
age based on interviews with family, birth attendants and/
or available medical records. Live born infants met the case
definition for PSBI if they fulfilled one of the following cri-
teria: 1) Presence of breathing problems/difficulty breath-
ing, feeding problems/stopped suckling or feeding, high
fever (T > 38C or estimated by touch), hypothermia (T <
35C or estimated by touch), convulsions, or bleeding/pus-
like discharge from the umbilicus, 2) Cause of death coded
as “infection”, or 3) Presence of free text entries under sec-
tions on symptoms or cause of death with any symptom
listed in criteria 1, infection, sepsis, possible sepsis, menin-
gitis, and/or pneumonia. There was no clinical confirm-
ation of symptoms, information on timing of symptoms,
nor did we have the ability to collect laboratory or micro-
biological data.
Statistical analysis
Poisson regression models with robust variance estima-
tion were used to assess whether maternal, peripartum
and neonatal characteristics were associated with PSBI
and to estimate risk ratios (RR) between groups [17, 18].
Generalized estimating equations with an independent
working correlation structure and robust parameter co-
variance estimates were used to adjust for clustering by
primary health center. We first estimated unadjusted
risk ratios between PSBI and individual risk factors po-
tentially associated with PSBI based on published litera-
ture and biological plausibility that were collected
reliably in the MNHR. We then included all potential
risk factors in a multivariable model for the purpose of
estimating adjusted risk ratios. We included maternal,
peripartum and neonatal factors, as well as year of deliv-
ery as a categorical variable to account for trends over
time. Data were analyzed using STATA (version 14) [19].
We performed a sensitivity analysis to assess the rela-
tionship between the risk factors and two modified out-
come variables classifying PSBI in a more restrictive
manner. We first excluded those with breathing problems
as a single symptom (Modified PSBI Outcome Variable 1),
and then excluded those with breathing or feeding prob-
lems as a single symptom (Modified PSBI Outcome Vari-
able 2). We did this to create a more specific outcome
variable since breathing problems were present in 50 % of
PSBI cases and could indicate a spectrum of symptoms, in-
cluding transient respiratory distress following delivery, fast
breathing (RR > 60), which is considered the least severe of
the clinical signs that predict severe illness, or a more con-
cerning sign such as severe chest indrawing [3, 20]. Feeding
problems as a single symptom was excluded in Modified
PSBI Outcome Variable 2 because it could also represent
varying levels of difficulty, such as poor latch at birth, or a
more serious sign such as inability to feed.
Ethical approval
The study was approved by the ethics committees of Lata
Medical Research Foundation, Partners Human Research
Committee, and RTI International. Prior to MNHR study
initiation, sensitization meetings were conducted for
local community approval. Informed consent was obtained
from all study participants. A data monitoring committee
appointed by the Eunice Kennedy Shriver National Insti-
tute of Child Health and Human Development (NICHD)
reviews the MNHR annually. This trial is registered at
ClinicalTrials.gov (NCT01073475).
Results
During the study period, we recorded 39,096 deliveries
and 38,499 live births. Of the live births, 37,379 single-
ton infants (97 %) weighing 1.5 kg or more at birth met
our inclusion criteria (Fig. 1). Of these, 2,123 (6.0 %) met
the criteria for PSBI. The case fatality rate was 23 %
(493/2123). Maternal, delivery, and infant characteristics
are listed in Table 1.
Clinical Characteristics of Infants with PSBI
Among infants with PSBI, breathing problems was the
most common symptom reported (50 %), followed by
fever (38 %) and feeding problems (35 %) (Table 2). Most
cases (74 %) were identified by a single symptom.
Factors Associated with PSBI
When potential risk factors were examined individually,
risk of PSBI was increased for mothers who were youn-
ger than 20 years of age, and mothers who were nul-
liparous or had a parity > 2 (when compared to those
with a parity of 1–2) (Table 3). Antenatal and delivery
characteristics associated with PSBI included no ante-
natal care or first antenatal care visit during the second
or third trimester (when compared to first trimester)
and antenatal corticosteroids. Infant characteristics asso-
ciated with PSBI included low birth weight, lack of early
initiation of breastfeeding and male sex.
On multivariable analysis, low birth weight (RR 3.10,
95 % confidence interval [CI] 2.17–4.42) and lack of
early initiation of breastfeeding (RR 3.87, 95 % CI 2.69–
5.58) were highly associated with risk of PSBI. Other
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characteristics associated with a significantly increased
risk of PSBI included: nulliparity (RR 1.13, 95 % CI 1.03–
1.23), parity > 2 (RR 1.30, 95 % CI 1.07–1.57), first ante-
natal care visit in the second or third trimester (RR 1.46,
95 % CI 1.08–1.98), no antenatal care (RR 3.21, 95 % CI
1.66–6.20), antenatal corticosteroids (RR 2.04, 95 % CI
1.60–2.61), and male sex (RR 1.20, 95 % CI 1.10–1.31). C-
section delivery was associated with a lower risk of PSBI
(RR 0.48, 95 % CI 0.36–0.63).
Because we found an unexpected association between
C-section delivery and PSBI in the multivariate analysis
that was not present in the univariate analysis, we assessed
whether each of the other variables in the model could have
modified the effect of delivery mode on PSBI. We found
evidence of effect modification by early initiation of breast-
feeding. We assessed these associations further by including
a 4-category variable that combined delivery mode and
early initiation of breastfeeding (vaginal delivery/breastfeed-
ing within 1 h, vaginal delivery/no early breastfeeding,
C-section delivery/breastfeeding within 1 h, C-section
delivery/no early breastfeeding) in a second multivari-
able model that also included all the other variables
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Fig. 1 Study Profile
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Table 1 Maternal, delivery and infant characteristicsa
Infants with PSBI Infants without PSBI All infants
2,123 % 35,256 % 37,379 %
Year
2010 680 32 % 8,867 25 % 9,547 26 %
2011 546 26 % 8,622 24 % 9,168 25 %
2012 450 21 % 8,684 25 % 9,134 24 %
2013 447 21 % 9,083 26 % 9,530 25 %
Maternal age
<20 60 3 % 668 2 % 728 2 %
≥20 2,060 97 % 34,632 98 % 36,692 98 %
Maternal education
Primary or less 414 20 % 7,153 20 % 7,567 20 %
Secondary or more 1,707 80 % 28,049 80 % 29,756 80 %
Parity
0 1,118 53 % 16,817 48 % 17,935 48 %
1–2 935 44 % 17,520 50 % 18,455 49 %
>2 68 3 % 903 3 % 971 3 %
Maternal anemia
No anemia (Hgb ≥11) 191 9 % 3,072 9 % 3,263 9 %
Mild anemia (Hgb 10- < 11) 877 41 % 14,786 42 % 15,663 42 %
Moderate to severe anemia (Hgb <10) 1,035 49 % 16,837 48 % 17,872 48 %
Trimester of first antenatal care visit
First 1,304 61 % 26,855 76 % 28,159 75 %
Second or Third 453 21 % 5,814 16 % 6,267 17 %
Received antenatal care, no information on timing 364 17 % 2,566 7 % 2,930 8 %
No antenatal care 2 0.1 % 13 0.04 % 15 0.04 %
Location of delivery
Referral government 935 44 % 15,688 44 % 16,623 44 %
Referral private 417 20 % 7,961 23 % 8,378 22 %
First level facility 656 31 % 10,276 29 % 10,932 29 %
Home/Other 110 5 % 1,304 4 % 1,414 4 %
Mode of delivery
Vaginal 1,686 79 % 28,265 80 % 29,951 80 %
C-sectionb 437 21 % 6,991 20 % 7,428 20 %
Prolonged or obstructed labor or failure to progress
Yes 308 15 % 4,406 12 % 4,714 13 %
No 1,812 85 % 30,803 87 % 32,615 87 %
Antenatal corticosteroids
Yes 119 6 % 779 2 % 898 2 %
No 1,986 94 % 34,410 98 % 36,396 97 %
Birth Weight
Normal birth weight (≥ 2500 gm) 1,325 62 % 31,009 88 % 32,334 87 %
Low birth weight (1500- < 2500 gm) 798 38 % 4,247 12 % 5,045 13 %
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included in the primary model. The rate of early initiation
of breastfeeding following vaginal delivery was 96 %,
compared to 49 % for C-sections (Table 4). When com-
pared to babies delivered by vaginal delivery who initiated
breastfeeding within one hour after delivery, the risk of
PSBI was not significantly different for babies delivered by
C-section who had early initiation of breastfeeding (RR
0.78, 95 % CI 0.58–1.04). However, the risk of PSBI was
significantly higher among babies delivered by C-section
who did not have early initiation of breastfeeding (RR
1.66, 95 % CI 1.30–2.11) and highest among babies deliv-
ered by vaginal delivery who did not have early initiation
of breastfeeding (RR 4.74, 95 % CI 3.13–7.17). The sub-
group of infants who were born by vaginal delivery and
were not breastfed early had a higher percentage of low
birth weight infants (375/1202, 31 %) and a higher case fa-
tality rate (195/1202, 16.2 %) when compared with the
three other sub-groups. Infants born by vaginal delivery
who were breastfed early had 13 % low birth weight in-
fants (3,640/28,642) with a case fatality rate of 1.2 % (333
deaths); infants born by C-section who were breastfed
early had 13 % low birth weight infants (459/3595) and a
case fatality rate of 1.3 % (48 deaths); and those delivered
by C-section who were not breastfed early had 14 % low
birth weight infants (541/3778) and a case fatality rate of
1.9 % (72 deaths).
Sensitivity analysis
After exclusion of cases based on breathing problems as a
single symptom, the characteristics significantly associated
with PSBI remained the same (Additional file 1: Table S1).
Results were also similar after exclusion of cases based on
either breathing or feeding problems as a single symptom
with the exception that the risk of PSBI for parity > 2 com-
pared to 1–2 was no longer significantly different.
Discussion
Our results show that PSBI occurred in 6 % of babies
born to a population-based cohort of 37,379 pregnant
women in rural central India, where 96 % of deliveries
occurred in facilities. This is similar to the 5.1 % rate of
PSBI found in a large community-based study in Ghana
where 68 % of deliveries occurred in a facility [21]. It is
also consistent with the pooled estimate of PSBI inci-
dence in South Asia (7.2 %, 95 % CI 5.0–9.3) developed
by Seale et al. using data from multiple studies [2]. How-
ever our estimate was lower than the 14.4 % and 9.2 %
rates found in community-based studies in Bangladesh
[22] and Nepal [23], respectively, where the majority of
deliveries (>80 %) occurred at home.
Table 1 Maternal, delivery and infant characteristicsa (Continued)
Initiation of breastfeeding within 1 hour after delivery
Yes 1,470 69 % 30,767 87 % 32,237 86 %
No 634 30 % 4,346 12 % 4,980 13 %
Sex
Male 1192 56 % 18,301 52 % 19,493 52 %
Female 931 44 % 16,950 48 % 17,881 48 %
aAll variables had less than 2 % missing data
bThe most common primary indications for C-section delivery were: prolonged labor/failure to progress (47 %), previous C-section (16 %), transverse/breech delivery (12 %),
no clear indication (8 %), fetal distress (8 %) and severe pre-eclampsia (3 %)
Table 2 Reported symptoms of infants with possible serious
bacterial infection
Number Percent
Total Number of PSBI Cases 2123
Number of symptoms present
No symptoms indicateda 26 1 %
1 1505 74 %
2 461 23 %
≥ 3 131 6 %
Breathing Problems
Only symptom 540 25 %
With or without another symptom 1067 50 %
Feeding Problems
Only symptom 288 14 %
With or without another symptom 737 35 %
Fever (T > 38C)
Only symptom 598 28 %
With or without another symptom 804 38 %
Hypothermia (T < 35C)
Only symptom 28 1 %
With or without another symptom 151 7 %
Convulsions
Only symptom 15 1 %
With or without another symptom 48 2 %
Bleeding/pus-like discharge from the umbilicus
Only symptom 36 2 %
With or without another symptom 48 2 %
aThese 26 infants did not have symptoms indicated because they fulfilled the
case definition of PSBI through cause of death or free text entries that did not
indicate specific symptoms
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(95 % Confidence Interval) Adjusted
Risk Ratioa
(95 % Confidence Interval)
Year
2010 7 % 1.00 1.00
2011 6 % 0.84 (0.60, 1.17) 0.81 (0.57, 1.15)
2012 5 % 0.69 (0.48, 1.00) 0.66 (0.46, 0.93)
2013 5 % 0.66 (0.42, 1.04) 0.66 (0.36, 1.20)
Maternal age
<20 8 % 1.46 (1.21, 1.70) 1.11 (0.93, 1.32)
≥ 20 6 % 1.00 1.00
Maternal education
Primary or less 5 % 0.95 (0.87, 1.05) 0.89 (0.80, 1.00)
Secondary or more 5 % 1.00 1.00
Parity
0 6 % 1.23 (1.11, 1.36) 1.13 (1.03, 1.23)
1–2 5 % 1.00 1.00
>2 7 % 1.38 (1.15, 1.66) 1.30 (1.07, 1.57)
Maternal anemia
No anemia (Hgb ≥11) 6 % 1.00 1.00
Mild anemia (Hgb 10- < 11) 6 % 0.96 (0.71, 1.30) 0.96 (0.79, 1.16)
Moderate to severe anemia (Hgb <10) 6 % 0.99 (0.58, 1.70) 0.92 (0.64, 1.31)
Trimester of first antenatal care visit
First 5 % 1.00 1.00
Second or Third 7 % 1.56 (1.12, 2.17) 1.46 (1.08, 1.98)
Received antenatal care, no information on timing 12 % 2.68 (1.65, 4.36) 2.27 (1.29, 4.00)
No antenatal care 13 % 2.88 (1.40, 5.93) 3.21 (1.66, 6.20)
Location of delivery
Referral government 6 % 1.00 1.00
Referral private 5 % 0.89 (0.67, 1.17) 0.83 (0.65, 1.06)
First level facility 6 % 1.07 (0.88, 1.30) 1.14 (1.00, 1.30)
Home/Other 8 % 1.38 (1.04, 1.84) 1.16 (0.86, 1.57)
Mode of delivery
Vaginal 6 % 1.00 1.00
C-section 6 % 1.04 (0.88, 1.25) 0.48 (0.36, 0.63)
Prolonged or obstructed labor or failure to progress
Yes 7 % 1.18 (0.84, 1.64) 1.22 (0.87, 1.69)
No 6 % 1.00 1.00
Antenatal corticosteroids
Yes 13 % 2.43 (1.86, 3.16) 2.04 (1.60, 2.61)
No 5 % 1.00 1.00
Birth Weight
Normal birth weight (≥ 2500 gm) 4 % 1.00 1.00
Low birth weight (1500- < 2500 gm) 16 % 3.86 (2.68, 5.55) 3.10 (2.17, 4.42)
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In this population-based study with a majority of facil-
ity deliveries, many of the factors associated with PSBI
were similar to those previously reported in babies ad-
mitted to facilities [6–8]. Factors that were associated
with an increased risk of PSBI in our population in-
cluded low birth weight, nulliparity, parity > 2, first ante-
natal care visit after the first trimester or no antenatal
care, lack of early initiation of breastfeeding, antenatal
corticosteroids, and male sex.
Within low-resource settings, low birth weight is an
established risk factor for neonatal mortality and has
been shown to be a risk factor for neonatal sepsis in
facility-based studies [1, 6–8, 24]. Nulliparity has also
been shown to be associated with early onset sepsis in a
large South African cohort (RR 1.8; 95 % CI 1.4–2.3) [7].
In that cohort, nulliparity was associated with a number
of traditional sepsis risk factors, such as prolonged labor
and greater number of vaginal examinations. Appropri-
ate antenatal care has been associated with improved
neonatal outcomes [9]. A facility-based study in Uganda
found that no antenatal care was associated with a 3-
times higher odds of culture-confirmed sepsis compared
to mothers who did receive antenatal care (odds ratio
3.21, 95 % CI 1.24–8.33) [25].
The finding of a lower rate of PSBI among C-section
deliveries in the multivariable model was unexpected.
Differences in reasons for not breastfeeding early may
have contributed to this finding. In the babies who did
receive early breastfeeding, risk of PSBI did not differ by
delivery type. In the babies who were not breastfed early,
the risk of PSBI was higher in vaginal deliveries com-
pared to C-sections. This suggests that the difference in
PSBI rates seen between vaginal and C-section deliveries
may have been driven by the population of babies that
was not breastfed early and their differences in baseline
risk. The small percentage of babies delivered vaginally
who were not breastfed early (4 %) may have been sicker,
requiring medical attention that prevented breastfeeding
immediately after birth. In contrast, 51 % of babies deliv-
ered by C-section did not have early breastfeeding, which
was more likely due to maternal post-operative recovery ra-
ther than an indicator of the health of the baby. Neverthe-
less, babies delivered by C-section who were not breastfed
early had a higher risk of PSBI compared to babies deliv-
ered by C-section who were. Breastfeeding has been associ-
ated with decreased rates of neonatal sepsis and other
neonatal infections [26, 27]. One meta-analysis found that
initiation of breastfeeding within 24 h of birth was associ-
ated with a lower neonatal mortality rate (RR 0.55, 95 % CI
0.36–0.84) [28]. As more births are occurring in facilities
and the percentage of C-sections are rising [29], improving
rates of early initiation of breastfeeding following C-section
is a potentially important area for intervention.
Our finding of the association between antenatal corti-
costeroids and PSBI deserves further exploration. Ante-
natal corticosteroids have been shown to reduce neonatal
morbidity and mortality from pre-term birth in hospitals
[30]. However, a recent cluster-randomized trial of ante-
natal corticosteroid use in six low- and middle-income
countries showed an increased 28-day neonatal mortality
rate in the group who received corticosteroids (RR 1.12,
95 % CI 1.02–1.22) [15]. This may have been due to the
administration of corticosteroids to women thought to be
at risk for preterm birth who ultimately delivered late
Table 3 Association of maternal, delivery and infant characteristics with possible serious bacterial infection (Continued)
Initiation of breastfeeding within 1 hour after delivery
Yes 5 % 1.00 1.00
No 13 % 2.79 (1.95, 3.98) 3.87 (2.69, 5.58)
Sex
Male 6 % 1.17 (1.07, 1.29) 1.20 (1.10, 1.31)
Female 5 % 1.00 1.00
a36,410 of 37,379 (97 %) observations were included in the multivariable model
Table 4 Interaction between delivery mode and early initiation of breastfeeding with outcome of possible serious bacterial infection
Number (%) with PSBI Total Number of Infants (%) Adjusted Risk Ratioa 95 % CI
Vaginal Delivery
Early Initiation of Breastfeeding 1346 (4) 28,642 (96) 1.00
Lack of early initiation of breastfeeding 330 (27) 1,202 (4) 4.74 (3.13–7.17)
C-section
Early Initiation of Breastfeeding 124 (3) 3,595 (49) 0.78 (0.58–1.04)
Lack of early initiation of breastfeeding 304 (8) 3,778 (51) 1.66 (1.30–2.11)
aMultivariable regression model adjusted for year, age, parity, maternal education, timing of first antenatal care visit, maternal anemia, location of delivery,
prolonged labor, infant sex, birth weight, and the 4-level variable listed above combining delivery mode and breastfeeding status
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preterm or term infants. On secondary analysis of these
data, there was no significant increase in risk of PSBI in the
intervention clusters who received antenatal corticosteroids
when compared to the control clusters [31]. When the
composite outcome of PSBI and death was analyzed, risk
was increased in the intervention clusters (RR 1.17, 95 % CI
1.04–1.30), which was driven by the difference among
infants with a birth weight greater than or equal to the 25th
percentile. Within our study population of babies with birth
weight ≥ 1.5 kg, corticosteroids may have resulted in a
compromised immune system and increased risk for infec-
tion in the neonate if the corticosteroids were administered
to the mother after week 34 of pregnancy. It is also possible
that our PSBI outcome variable misclassified cases because
it was based only on reported symptoms. Therefore, further
study of antenatal corticosteroid use and its relationship
with neonatal infection as assessed by clinical and labora-
tory criteria is urgently required as antenatal corticosteroids
are being scaled up in low-resource settings [32].
This study has important strengths. We determined
rates of PSBI up to 42 days of age in a large, population-
based cohort of mothers and babies over a four-year
period. Trained study staff prospectively collected infor-
mation on PSBI, risk factors and outcomes, reducing the
risk of selection bias when babies admitted to facilities
with PSBI are studied. Our study also has several limita-
tions. First, PSBI was defined on the basis of clinical
signs and symptoms, not laboratory data or microbio-
logical confirmation of infection. However, because labora-
tory diagnosis of infection in young infants is difficult in
resource-limited settings, identification of PSBI has trad-
itionally relied on versions of the definition used in this
study [2]. Secondly, we did not have the ability to deter-
mine the exact timing of PSBI symptoms, nor did we re-
quire clinical confirmation of the symptoms. Questions
regarding the symptoms of breathing or feeding problems,
which are the least objective measures, may have been
interpreted differently by respondents and/or study staff.
We addressed this issue by excluding the babies with
breathing or feeding problems as a single symptom in our
sensitivity analysis and obtained results similar to those
from the primary analysis. Third, the MNHR was not spe-
cifically designed to assess rates of PSBI and therefore does
not include all factors that may be associated with PSBI,
such as the duration of rupture of membranes, maternal
fever, etc. We also did not include gestational age in our
analysis and are thus unable to separate the effect of birth
weight from that of prematurity. We chose not to include
estimates of gestational age based on last menstrual period
dating due to the poor reliability of this dating in our
population and the inability to confirm dates with ultra-
sound. Lastly, because the study was completed at a single
site in India, which consists of many diverse states, the
findings may not be representative of the entire country.
Conclusions
Since neonatal infections are the third most common
cause of neonatal deaths worldwide and the leading
cause of death in the late neonatal period (7–27 days)
[1], achieving significant reductions in neonatal mortality
requires improvements in the identification and treat-
ment of neonatal infections. Our study in a large rural
population-based cohort around Nagpur, India, with a
high rate of facility delivery, showed that many of the
known risk factors for PSBI such as low birth weight
and late or no antenatal care, were still present. Our data
suggest that infants born to nulliparous women, women
who present late to antenatal care, those receiving ante-
natal corticosteroids and infants who are low birth
weight could be targeted for extra antenatal and post-
natal visits for early recognition of signs and symptoms
of PSBI and prompt referral. Promoting early breastfeed-
ing following C-section may also be a potential oppor-
tunity for intervention.
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